ESR1 and breast carcinoma: Later, Basal-like breast cancer (BLBC) was defined as estrogen receptor (ER) negative, human epidermal growth factor receptor 2 (Her-2) negative; epidermal growth factor receptor (EGFR, also known as Her-1) or/and Cytokeratin 5/6 (CK 5/6) positive [5].